New Analyses from Three Trials in Obstructive HCM Support Findings from Previously Published Data on MYQORZO™ (aficamten)SOUTH SAN FRANCISCO, ...

ScotusCrim is a recurring series by Rory Little focusing on intersections between the Supreme Court and criminal law. Imagine: A group of drug dealers beat and shoot dead a citizen they felt was ...

Credit: Getty Images HCM is a genetic disease, usually caused by mutations in sarcomere proteins such as myosin, actin, tropomyosin, and myosin-binding protein C. Hypertrophic cardiomyopathy (HCM) ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the cheap S&P 500 stocks to invest in now. On January 12, Bristol-Myers Squibb announced positive topline results from its Phase 3 SCOUT-HCM clinical ...

Positive results support the potential for Camzyos to be the first cardiac myosin inhibitor for the treatment of adolescent oHCM PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (BMY) (NYSE: ...

Positive results support the potential for Camzyos to be the first cardiac myosin inhibitor for the treatment of adolescent oHCM “The SCOUT-HCM study is important for patients and the field of ...

A statistically significant reduction from baseline in Valsalva LVOT gradient was observed with mavacamten vs placebo at week 28. Topline data were announced from a phase 3 trial evaluating mavacamten ...

Myqorzo is expected to be available by the second half of January 2026. The Food and Drug Administration (FDA) has approved Myqorzo™ (aficamten) for the treatment of adults with symptomatic ...

Aficamten offers a new treatment option for symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Clinical trials SEQUOIA-HCM and MAPLE-HCM showed aficamten's efficacy in improving exercise ...

A Wisconsin judge was found guilty late Thursday of obstruction charges for helping a Mexican immigrant evade federal authorities after learning of his imminent arrest, but she was acquitted of ...

A jury found a Wisconsin judge – accused of helping an undocumented immigrant dodge federal authorities – guilty of obstruction Thursday, marking a victory for President Donald Trump as he continues ...